Overview
Transportation Equipment

Matsuya R&D Co.,Ltd

Matsuya R&D develops, manufactures, and sells proprietary sewing automation machines (automated sewing robots and cutting machines), while also operating contract manufacturing of sewn products using its own automated production lines. The company serves three key segments: Medical Healthcare (primarily blood pressure monitor cuffs manufactured for the Omron Group in Vietnam and Myanmar), Safety Systems (automotive safety components including car seats, airbags, and interior parts, as well as sewing automation equipment for airbag and seatbelt manufacturers), and Other (sewing automation solutions for furniture, interior, and apparel industries). With a track record of over 200 client companies across 20 countries, the company's competitive strength lies in its unique business model combining proprietary automation equipment development with contract manufacturing, enabling synergies across both revenue streams.

Market Cap
¥23.6B
US$150M
EV
¥21.7B
US$138M
Stock¥1,103▲+0.00%
US$1 = ¥157.05 (2026-10-22)
LTM EV/EBITDA
9.4
x
LTM EV/EBIT
10.2
x
LTM PER
15.2
x
LTM PBR
2.9
x
Stock vs TOPIX (1Y, base=100)vs TOPIX ▲+13.7%pt
1001
Oct 23, 25 – Jul 16, 26StockTOPIX
1Dec 16, 25TOB announcement by Omron Healthcare (12/15)
MC → EV Bridge
23.6BUS$150MMarket Cap2.47BUS$15.8M+ Debt4.41BUS$28.0M− Cash0.00BUS$0.00M− Inv. Sec.21.7BUS$138MEV
AI Briefing
Generating insights…
Performance & Balance
Revenue 5Y (¥B)
5.64US$35.9M'22/37.16US$45.6M'23/38.43US$53.7M'24/39.57US$60.9M'25/39.77US$62.2M'26/3
EBITDA 5Y (¥B)
0.58US$3.72M'22/30.88US$5.60M'23/31.56US$9.92M'24/32.15US$13.7M'25/32.32US$14.7M'26/3
Net Income 5Y (¥B)
0.17US$1.05M'22/30.43US$2.71M'23/30.95US$6.07M'24/31.56US$9.93M'25/31.55US$9.86M'26/3
Capital Structure
77%
23%
EquityD/E 0.30xDebt
Liquidity vs Debt 5Y (¥B)▲ Net Cash
CashInv. Sec.Debt
1.49US$9.50M1.81US$11.5M'22/32.34US$14.9M3.09US$19.7M'23/32.25US$14.3M2.84US$18.1M'24/34.14US$26.3M2.49US$15.8M'25/34.41US$28.0M2.47US$15.8M'26/3
Shareholders
Top 10 hold 79.2%
1
Tomohiro GOTO
16.80%
2
Masahiro GOTO
16.80%
3
Omron Healthcare Co., Ltd.
14.77%
4
Gotoh Holdings Co., Ltd.
9.34%
5
Hidetaka GOTO
8.78%
6
MAEDA KOSEN CO.,LTD.
3.73%
7
Morgan Stanley MUFG Securities Co., Ltd.
3.45%
8
Ueda Yagi Tanshi Co., Ltd.
2.33%
9
JPMorgan Securities Japan Co., Ltd.
1.74%
10
JP JPMSE LUX REUBSAG LONDON BRANCH EQCO (Standing Proxy: MUFG Bank, Ltd.)
1.42%
Management
6 officers
Hidetaka GOTO
Representative Director, President & CEO (concurrently President Executive Officer)
Aug 1982 Established Matsuya Sewing Machine Sales Co., Ltd. (now the Company), Representative Director, President Aug 2007 Chairman, Matsuya Trading (Shanghai) Co., Ltd. (current) May 2008 Chairman, Matsuya R&D (Vietnam) Co., Ltd. (current) Dec 2014 Representative Director, Matsuya R&D (Myanmar) Co., Ltd. (current) Jul 2017 Representative Director, President, Takahater Co., Ltd. (resigned Mar 2018) Jan 2019 Representative Director, President, Takahater Co., Ltd. (resigned Dec 2024) Aug 2020 Representative Director, President and CEO, the Company Jun 2021 Representative Director, President and CEO (concurrently President Executive Officer), the Company (current)
1950-01-22
Koichi MATSUKAWA
Managing Director, CFO (concurrently Managing Executive Officer), General Manager, Corporate Management Division
Dec 2006 Joined ShinNihon Audit Corporation (now EY ShinNihon LLC) Oct 2011 Registered as Certified Public Accountant Jan 2018 Joined the Company Jul 2018 General Manager, Accounting Department, the Company Nov 2018 General Manager, Accounting Department and Manager, Finance Section, the Company Dec 2018 Director, General Manager, Accounting Department and Manager, Finance Section, the Company Oct 2019 Director, General Manager, Accounting Department, the Company Aug 2020 Managing Director, CFO, General Manager, Corporate Management Division, the Company Director, Takahater Co., Ltd. (resigned Jan 2025) Jun 2021 Managing Director, CFO (concurrently Managing Executive Officer), General Manager, Corporate Management Division, the Company (current)
1982-12-14
Yutaka SASAKI
Director
Apr 1980 Joined Chugai Boeki Co., Ltd. (now CBC Co., Ltd.) Apr 2003 Director, Chugai Boeki Co., Ltd. Apr 2009 Managing Director, Chugai Boeki Co., Ltd. May 2014 Established Visalight Co., Ltd., Representative Director (current) Feb 2016 Outside Director (Audit and Supervisory Committee Member), Trace-on-Product Co., Ltd. (formerly Transas Co., Ltd.) (resigned Apr 2026) Apr 2016 Established Visalight Works Co., Ltd., Representative Director (current) Dec 2018 Outside Director, the Company (current) May 2020 Outside Director, Boolean Co., Ltd. (current)
1956-09-29
Isamu AKAZAWA
Standing Audit & Supervisory Board Member
Oct 1997 Joined the Company Aug 2007 General Manager, Manufacturing Control Department, the Company Jun 2013 Director, General Manager, Manufacturing Control Department, the Company Jun 2021 Managing Executive Officer, General Manager, Sales Division I, the Company Oct 2024 Executive Officer, Deputy General Manager, Medical Healthcare Business Division, the Company Jun 2025 Audit & Supervisory Board Member, the Company (current)
1960-08-07
Mitsuhiro NISHIKIMI
Audit & Supervisory Board Member
Apr 1988 Joined Azsa LLC (formerly Eiwa Audit Corporation) Mar 1991 Registered as Certified Public Accountant Opened Mitsuhiro Nishikimi Certified Public Accountant Office, Representative (current) Established Centaur Concept Co., Ltd., Representative Director (current) Jun 2008 Outside Director, Eat&Co., Ltd. (now Eat&Holdings Co., Ltd.) Jun 2015 Outside Director (Audit and Supervisory Committee Member), Eat&Co., Ltd. (current) Jun 2017 Outside Audit & Supervisory Board Member, the Company (current) Sep 2019 Audit & Supervisory Board Member, Matsuya R&D (Vietnam) Co., Ltd. (current)
1963-05-13
Keigo URUMA
Audit & Supervisory Board Member
Dec 2012 Registered as Attorney-at-Law; joined Kuzuryu Law Office (current) Dec 2018 Outside Audit & Supervisory Board Member, the Company (current)
1987-09-08
Large Shareholding Reports
Omron Healthcare Co., Ltd.
2026-06-29
96.41%→99.98%
Annual report (as of 2026-03-31): 14.77%
Omron Healthcare Co., Ltd.
2026-06-19
14.97%→96.41%
Annual report (as of 2026-03-31): 14.77%
Masahiro GOTO
2026-06-18
16.80%→0.00%
Annual report (as of 2026-03-31): 16.80%
Masahiro GOTO
2026-05-11
16.80%→16.80%
Annual report (as of 2026-03-31): 16.80%
Tomohiro GOTO
2026-04-27
16.80%→16.80%
Annual report (as of 2026-03-31): 16.80%
Masahiro GOTO
2026-04-24
16.82%→16.80%
Annual report (as of 2026-03-31): 16.80%
Masahiro GOTO
2025-12-19
16.84%→16.82%
Annual report (as of 2026-03-31): 16.80%
Tomohiro GOTO
2025-10-17
16.84%→16.84%
Annual report (as of 2026-03-31): 16.80%
Masahiro GOTO
2025-10-17
16.84%→16.84%
Annual report (as of 2026-03-31): 16.80%
Tomohiro GOTO
2025-09-25
16.84%→16.84%
Annual report (as of 2026-03-31): 16.80%
Masahiro GOTO
2025-09-11
16.84%→16.84%
Annual report (as of 2026-03-31): 16.80%
Tomohiro GOTO
2025-09-09
16.86%→16.84%
Annual report (as of 2026-03-31): 16.80%
Masahiro GOTO
2025-09-08
17.06%→16.90%
Annual report (as of 2026-03-31): 16.80%
Tomohiro GOTO
2025-09-08
16.90%→16.84%
Annual report (as of 2026-03-31): 16.80%
Masahiro GOTO
2025-09-01
16.86%→16.86%
Annual report (as of 2026-03-31): 16.80%
Masahiro GOTO
2025-08-22
16.90%→16.86%
Annual report (as of 2026-03-31): 16.80%
Disclosures
No disclosures
Primary Source Filings
EDINET
2026-06-29
Large Shareholding Report
EDINET
2026-06-26
Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINET
2026-06-19
Large Shareholding Report
EDINET
2026-06-18
Large Shareholding Report
EDINET
2026-06-16
公開買付報告書
EDINET
2026-05-19
公開買付届出書
EDINET
2026-05-19
意見表明報告書
EDINET
2026-05-11
Large Shareholding Report
EDINET
2026-04-27
Large Shareholding Report
EDINET
2026-04-24
Large Shareholding Report
TDnet
2026-02-10
Q3 Earnings Flash
FY ending Mar 2026
EDINET
2025-12-19
Large Shareholding Report
EDINET
2025-11-10
Semi-Annual Securities Report
Period: Apr 2025 – Mar 2026
EDINETAmended
2025-10-17
Change Report
EDINETAmended
2025-10-17
Change Report
EDINET
2025-09-25
Large Shareholding Report
EDINET
2025-09-11
Large Shareholding Report
EDINETAmended
2025-09-09
Change Report
EDINETAmended
2025-09-08
Change Report
EDINETAmended
2025-09-08
Change Report
EDINET
2025-09-01
Large Shareholding Report
EDINET
2025-08-22
Large Shareholding Report
TDnet
2025-08-08
Q1 Earnings Flash
FY ending Mar 2026
EDINET
2025-06-23
Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2025-02-10
Q3 Earnings Flash
FY ending Mar 2025
EDINET
2024-11-08
Semi-Annual Securities Report
Period: Apr 2024 – Mar 2025
TDnet
2024-08-09
Q1 Earnings Flash
FY ending Mar 2025
EDINET
2024-06-28
Annual Securities Report
Period: Apr 2023 – Mar 2024
EDINET
2024-02-09
Quarterly Securities Report
Period: Oct 2023 – Dec 2023
EDINET
2023-11-10
Quarterly Securities Report
Period: Jul 2023 – Sep 2023
Ask AI
I have this company's financials, ownership, and management on hand. Ask me anything from an M&A perspective.
End of Preview

Try the full product

Free demo (no time limit, up to 10 companies). Explore Comps, DCF, LBO, WACC on every screen. Excel export is on the paid plan.

Free Demo (No Time Limit, 10 Companies) →